Novartis Investigative Site

Leningrad Region, Russia 188663

0 studies enrolling now · 4 studies all time

What they study most

Breast Cancer, Head and Neck Squamous Cell Carcinoma, Metastatic Renal Cell Carcinoma, Neoplasms

Studies at this site

• Study to Assess the Safety and Efficacy of Ribociclib (LEE011) in Combination With Letrozole for the Treatment of Men and Pre/Postmenopausal Women With HR+ HER2- aBC — Completed
• Everolimus Roll-over Protocol for Patients Who Have Completed a Previous Novartis-sponsored Everolimus Study. — Completed
• Study of Efficacy and Safety of Buparlisib (BKM120) Plus Paclitaxel Versus Placebo Plus Paclitaxel in Recurrent or Metastatic Head and Neck Cancer Previously Pre-treated With a Platinum Therapy — Stopped early
• Everolimus as Second-line Therapy in Metastatic Renal Cell Carcinoma — Completed